EBR EBR Systems, Inc.
Healthcare · Medical Devices
· website
· 135 employees
$0.27
52wk 0.24 – 1.47
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About EBR Systems, Inc.
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$199.63M
P/E (trailing)
1.66
P/E (forward)
-0.26
EPS (trailing)
0.16
Dividend yield
—
Payout ratio
0.0%
Beta
0.52
EV / EBITDA
-3.08
Price / Book
8.82
ROE
-458.8%
Operating margin
-684.7%
Net margin
0.0%
Total cash
$29.87M
Total debt
$59.53M
Current ratio
4.48
Debt / Equity
6.24
Free cash flow
$-51.07M
Avg volume
2.67M
Latest annual results
(FY ending 31 Dec 2025)
- Revenue$1.62M
- Gross profit$490.00K
- Operating income-$46.09M
- Net income-$48.76M
- Diluted EPS-0.11
- Free cash flow-$56.88M
- Net debt$52.79M